Market revenue in 2023 | USD 242.2 million |
Market revenue in 2030 | USD 367.5 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Attenuated vaccine |
Fastest growing segment | DNA Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines |
Key market players worldwide | Lonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 29.77% in 2023. Horizon Databook has segmented the UK vaccine contract manufacturing market based on attenuated vaccine, inactivated vaccine, subunit vaccines, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is of prime importance for pharmaceutical companies due to its extensive R&D initiatives, excellent early innovation medicine platform, and pharmaceutical clinical trials being undertaken to address the challenges posed by various diseases.
In addition, the pharmaceutical manufacturers in the country are focusing on innovation of several forms of high value tablet products in bulk, which has created requirement for vaccine contract manufacturing to assess their pharmaceutical products production with safety, efficacy, and quantity & quality.
Furthermore, increasing focus on research activities, expertise in characterization & functionality, high volume continuous production are responsible for the dominance of the UK in Europe market.
Horizon Databook provides a detailed overview of country-level data and insights on the UK vaccine contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account